<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">58081</article-id><article-id pub-id-type="doi">10.7554/eLife.58081</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title><italic>IER5</italic>, a DNA damage response gene, is required for Notch-mediated induction of squamous cell differentiation</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-188544"><name><surname>Pan</surname><given-names>Li</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-109974"><name><surname>Lemieux</surname><given-names>Madeleine E</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188545"><name><surname>Thomas</surname><given-names>Tom</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188546"><name><surname>Rogers</surname><given-names>Julia M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-202940"><name><surname>Lipper</surname><given-names>Colin H</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188547"><name><surname>Lee</surname><given-names>Winston</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188548"><name><surname>Johnson</surname><given-names>Carl</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188549"><name><surname>Sholl</surname><given-names>Lynette M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188550"><name><surname>South</surname><given-names>Andrew P</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-77304"><name><surname>Marto</surname><given-names>Jarrod A</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188551"><name><surname>Adelmant</surname><given-names>Guillaume O</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-31476"><name><surname>Blacklow</surname><given-names>Stephen C</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6904-1981</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-21920"><name><surname>Aster</surname><given-names>Jon C</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1957-9070</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><institution content-type="dept">Department of Pathology</institution>, <institution>Brigham and Women's Hospital</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution>Bioinfo</institution>, <addr-line><named-content content-type="city">Ontario</named-content></addr-line>, <country>Canada</country></aff><aff id="aff3"><institution content-type="dept">Biological Chemistry and Molecular Pharmacology</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Dermatology and Cutaneous Biology</institution>, <institution>Thomas Jefferson University</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">The Blais Proteomics Center</institution>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Oncologic Pathology</institution>, <institution>Dana Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Department of Biological Chemistry and Molecular Pharmacology</institution>, <institution>Harvard</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-175464"><name><surname>Sarin</surname><given-names>Apurva</given-names></name><role>Reviewing editor</role><aff><institution>Institute for Stem Cell Science and Regenerative Medicine</institution>, <country>India</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>jaster@rics.bwh.harvard.edu</email> (JA);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>16</day><month>09</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e58081</elocation-id><history><date date-type="received"><day>20</day><month>04</month><year>2020</year></date><date date-type="accepted"><day>15</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement>Â© 2020, Pan et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Pan et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-58081-v1.pdf"/><abstract><p>Notch signaling regulates squamous cell proliferation and differentiation and is frequently disrupted in squamous cell carcinomas, in which Notch is tumor suppressive. Here, we show that conditional activation of Notch in squamous cells activates a context-specific gene expression program through lineage-specific regulatory elements. Among direct Notch target genes are multiple DNA damage response genes, including <italic>IER5</italic>, which we show is required for Notch-induced differentiation of squamous carcinoma cells and TERT-immortalized keratinocytes. <italic>IER5</italic> is epistatic to <italic>PPP2R2A</italic>, a gene that encodes the PP2A B55a subunit, which we show interacts with IER5 in cells and in purified systems. Thus, Notch and DNA-damage response pathways converge in squamous cells on common genes that promote differentiation, which may serve to eliminate damaged cells from the proliferative pool. We further propose that crosstalk involving Notch and PP2A enables tuning and integration of Notch signaling with other pathways that regulate squamous differentiation.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009729</institution-id><institution>Ludwig Institute for Cancer Research</institution></institution-wrap></funding-source><award-id>None</award-id><principal-award-recipient><name><surname>Aster</surname><given-names>Jon C</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R35 CA220340</award-id><principal-award-recipient><name><surname>Blacklow</surname><given-names>Stephen C</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Stephen C Blacklow, SCB is on the SAB for Erasca, Inc., receives sponsored research funding from Novartis and Erasca, Inc, and is a consultant for IFM therapeutics and Ayala Pharmaceuticals..</p></fn><fn fn-type="conflict" id="conf3"><p>Jon C Aster, JCA is a consultant for Ayala Pharmaceuticals and for Cellestia, Inc. There is no conflict of interest with the work described in this manuscript..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession codes GSE156488 and GSE156624</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Pan L et al</collab></person-group><year iso-8601-date="2020">2020</year><source>Notch target genes in keratinocytes</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE156488">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE156488</ext-link><comment>NCBI GEne Expression Omnibus, GSE156488</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Pan L et al</collab></person-group><year iso-8601-date="2020">2020</year><source>Notch target genes in keratinocytes</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE156624">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE156624</ext-link><comment>NCBI GEne Expression Omnibus, GSE156624</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-58081-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>